Cargando…

TP53 Polymorphisms allow for genetic sub-grouping of the canine transmissible venereal tumor

The canine transmissible venereal tumor (CTVT) is found mainly in dogs' sexual organs. Currently, it is widely accepted that all samples of CTVT show similar histopathological characteristics and share common genetic alterations. Despite the common genetic origin of CTVT, mutations in the P53 g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-Servín, Abel, Martínez, Simón, Córdova-Alarcon, Emilio, Fajardo, Raúl
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Society of Veterinary Science 2009
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2807274/ https://www.ncbi.nlm.nih.gov/pubmed/19934603 http://dx.doi.org/10.4142/jvs.2009.10.4.353

Ejemplares similares

First report of venereal and vertical transmission of canine leishmaniosis from naturally infected dogs in Germany
por: Naucke, Torsten J, et al.
Publicado: (2012)

Molecular Signatures of Regression of the Canine Transmissible Venereal Tumor
por: Frampton, Dan, et al.
Publicado: (2018)

Role of TP53 polymorphisms in sub-Saharan mucosal cancers
por: Buonaguro, Franco M, et al.
Publicado: (2010)

The changing global distribution and prevalence of canine transmissible venereal tumour
por: Strakova, Andrea, et al.
Publicado: (2014)

Fibrosis in canine transmissible venereal tumor after chemotherapy with vincristine
por: Duzanski, Anderson do Prado, et al.
Publicado: (2023)

Presence of Papillomavirus DNA sequences in the canine transmissible venereal tumor (CTVT)
por: Ayala-Díaz, Sergio, et al.
Publicado: (2019)

Growth stage dependent expression of MHC antigens on the canine transmissible venereal sarcoma.
por: Yang, T. J., et al.
Publicado: (1987)

Canine transmissible venereal sarcoma: electron microscopic changes with time after transplantation.
por: Kennedy, J. R., et al.
Publicado: (1977)

Overexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor
por: Chiang, Hsin-Chien, et al.
Publicado: (2012)

A retrospective study of canine transmissible venereal tumour in Grenada, West Indies
por: Schectman, Sara J., et al.
Publicado: (2022)

In vitro chemosensitivity of a canine tumor venereal transmissible cancer cell line
por: Franco Molina, Moisés Armides, et al.
Publicado: (2022)

Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis
por: Yang, Y C, et al.
Publicado: (2006)

Association of polymorphisms in TP53 and the promoter region of IL10 with gastric cancer in a Kazakh population
por: Kulmambetova, Gulmira, et al.
Publicado: (2020)

Association of the TP53 rs1042522 C>G polymorphism and hepatoblastoma risk in Chinese children
por: Yang, Tianyou, et al.
Publicado: (2019)

Cell-based polymerase chain reaction for canine transmissible venereal tumor (CTVT) diagnosis
por: SETTHAWONGSIN, Chanokchon, et al.
Publicado: (2016)

The intratumor heterogeneity of TP53 gene mutations in canine histiocytic sarcoma
por: ASADA, Hajime, et al.
Publicado: (2019)

Canine transmissible venereal tumor: First report of three clinical cases from Tripoli, Libya
por: Hiblu, Murad A., et al.
Publicado: (2019)

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
por: McGraw, K L, et al.
Publicado: (2015)

Analysis of Tp53 Codon 72 Polymorphisms, Tp53 Mutations, and HPV Infection in Cutaneous Squamous Cell Carcinomas
por: Loeb, Keith R., et al.
Publicado: (2012)

Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk
por: Eiholzer, Ramona A., et al.
Publicado: (2020)

Canine Parvovirus ns1 gene and Chicken Anemia vp3 gene induce partial oncolysis of Canine Transmissible Venereal Tumor
por: Bhat, Aubid Hussain, et al.
Publicado: (2017)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

LAMP3 plays an oncogenic role in osteosarcoma cells partially by inhibiting TP53
por: Liu, Shaoxian, et al.
Publicado: (2018)

Computer tomographic imaging in 4 dogs with primary nasal canine transmissible venereal tumor and differing cellular phenotype
por: Ojeda, Javier, et al.
Publicado: (2018)

Evaluation of a Canine Transmissible Venereal Tumour Cell Line with Tumour Immunity Capacity but Without Tumorigenic Property
por: Zayas, Yareellys Ramos, et al.
Publicado: (2019)

Factor Analysis for Bicluster Acquisition (FABIA) revealed vincristine-sensitive transcript pattern of canine transmissible venereal tumors
por: Chokeshaiusaha, K., et al.
Publicado: (2019)

Intratumoral recombinant human interferon alpha‐2a and vincristine combination therapy in canine transmissible venereal tumour
por: Kanca, Halit, et al.
Publicado: (2018)

Conventional-Vincristine Sulfate vs. Modified Protocol of Vincristine Sulfate and L-Asparaginase in Canine Transmissible Venereal Tumor
por: Setthawongsin, Chanokchon, et al.
Publicado: (2019)

Immunophenotypic and molecular profile of cancer stem‐cell markers in ex vivo canine transmissible venereal tumour (CTVT)
por: Grandi, Fabrizio, et al.
Publicado: (2022)

Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma
por: Das, Sunetra, et al.
Publicado: (2021)

Targeted next-generation sequencing of TP53 in oral tongue carcinoma from non-smokers
por: Faden, Daniel L., et al.
Publicado: (2016)

Canine transmissible venereal sarcoma: distribution of T and B lymphocytes in blood, draining lymph nodes and tumours at different stages of growth.
por: Chandler, J. P., et al.
Publicado: (1981)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

TP53 intron 6 polymorphism and the risk of ovarian and breast cancer.
por: Mavridou, D., et al.
Publicado: (1998)

TP53 rs1042522 polymorphism and early-onset breast cancer
por: Icen-Taskin, Irmak, et al.
Publicado: (2020)

The genetic association study of TP53 polymorphisms in Saudi obese patients
por: Sabir, Jamal S.M., et al.
Publicado: (2019)

Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds
por: Alsaihati, Burair A., et al.
Publicado: (2021)

Establishment of TP53-knockout canine cells using optimized CRIPSR/Cas9 vector system for canine cancer research
por: Eun, Kiyoung, et al.
Publicado: (2019)

Chromosome instability in fibroblasts derived from Li–Fraumeni syndrome families without TP53 mutations
por: Boyle, J M, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_6nf0cvctc6h20g7k6ehdroi35b